Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5997-6000, November 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Somers, K. D.
Right arrow Articles by Casey, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Somers, K. D.
Right arrow Articles by Casey, G.

Frequent p53 Mutations in Head and Neck Cancer1

Kenneth D. Somers2, M. Anne Merrick, Martha E. Lopez, Leonard S. Incognito, Gary L. Schechter and Graham Casey3

Head and Neck Tumor Biology Program, Departments of Microbiology/Immunology [K. D. S., M. A. M., L. S. I.] and Otolaryngology—Head and Neck Surgery [K. D. S., M. A. M., G. L. S.], Eastern Virginia Medical School, Norfolk, Virginia 23501, and Department of Pediatrics, School of Medicine, University of California at Irvine, Irvine, California 92717 [M. E. L., G. G.]

Squamous cell carcinomas of the head and neck (SCCHN) are associated strongly with the use of tobacco and alcohol, but little is known about the molecular pathogenesis of these tumors. In the present study, we analyzed SCCHN for mutations in the tumor suppressor gene p53 by immunocytochemistry and complementary DNA sequencing. Overexpression of p53 protein was detected in 13 (100%) of 13 SCCHN cell lines and in tumor cells cultured directly from 10 (77%) of 13 patients with SCCHN. Direct evidence for p53 mutations was obtained by sequencing p53 complementary DNA from eight SCCHN cell lines and two tumor xenografts. The genetic alterations included seven missense mutations resulting in single amino acid substitutions, a mutation encoding a stop codon, one 10-base pair deletion, and one 2-base pair addition. All seven missense mutations were G to T transversions, five of which were clustered at codons 245 and 248. A similar high frequency of G to T transversions predominates in lung cancer, another tobacco-related disease. Mutation of the p53 gene is the most common genetic alteration detected in SCCHN and implicates this gene locus as a critical site of specific damage by mutagenic carcinogens in tobacco, one of the important risk factors in the etiology of this disease.

1 Supported by the Medical College of Hampton Roads Foundation.

2 To whom requests for reprints should be addressed.

3 Supported by Grant 1RT343 from the Oxnard Foundation, and the Tobacco-Related Disease Research Program (TRDRP).

Received 4/22/92. Accepted 8/25/92.




This article has been cited by other articles:


Home page
J. Dent. Res.Home page
S. Choi and J.N. Myers
Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
J. Dent. Res., January 1, 2008; 87(1): 14 - 32.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S Mitra, S Banerjee, C Misra, R K Singh, A Roy, A Sengupta, C K Panda, and S Roychoudhury
Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population
J. Clin. Pathol., September 1, 2007; 60(9): 1040 - 1047.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. H. Chung, J. S. Parker, K. Ely, J. Carter, Y. Yi, B. A. Murphy, K. K. Ang, A. K. El-Naggar, A. M. Zanation, A. J. Cmelak, et al.
Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-{kappa}B Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma
Cancer Res., August 15, 2006; 66(16): 8210 - 8218.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Tokumaru, K. Yamashita, M. Osada, S. Nomoto, D.-I. Sun, Y. Xiao, M. O. Hoque, W. H. Westra, J. A. Califano, and D. Sidransky
Inverse Correlation between Cyclin A1 Hypermethylation and p53 Mutation in Head and Neck Cancer Identified by Reversal of Epigenetic Silencing
Cancer Res., September 1, 2004; 64(17): 5982 - 5987.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Ginos, G. P. Page, B. S. Michalowicz, K. J. Patel, S. E. Volker, S. E. Pambuccian, F. G. Ondrey, G. L. Adams, and P. M. Gaffney
Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck
Cancer Res., January 1, 2004; 64(1): 55 - 63.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Freie, X. Li, S. L. M. Ciccone, K. Nawa, S. Cooper, C. Vogelweid, L. Schantz, L. S. Haneline, A. Orazi, H. E. Broxmeyer, et al.
Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis
Blood, December 1, 2003; 102(12): 4146 - 4152.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. G. Banerjee, V. K. Gopalakrishnan, I. Bhattacharya, and J. K. Vishwanatha
Deregulated Cyclooxygenase-2 Expression in Oral Premalignant Tissues
Mol. Cancer Ther., December 1, 2002; 1(14): 1265 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. A. Geisler, A. F. Olshan, M. C. Weissler, J. Cai, W. K. Funkhouser, J. Smith, and K. Vick
p16 and p53 Protein Expression as Prognostic Indicators of Survival and Disease Recurrence from Head and Neck Cancer
Clin. Cancer Res., November 1, 2002; 8(11): 3445 - 3453.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Forastiere, W. Koch, A. Trotti, and D. Sidransky
Head and Neck Cancer
N. Engl. J. Med., December 27, 2001; 345(26): 1890 - 1900.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Shintani, M. Mihara, N. Terakado, Y. Nakahara, T. Matsumura, Y. Kohno, H. Ohyama, J. McBride, R. Kent, R. Todd, et al.
Reduction of p12DOC-1 Expression Is a Negative Prognostic Indicator in Patients with Surgically Resected Oral Squamous Cell Carcinoma
Clin. Cancer Res., September 1, 2001; 7(9): 2776 - 2782.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. P. Schantz, Q. Huang, K. Shah, V.V.V.S. Murty, T.C. Hsu, G. Yu, P. E. Andersen, A. G. Huvos, and R. S.K. Chaganti
Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers
Carcinogenesis, June 1, 2000; 21(6): 1239 - 1246.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Cabelguenne, H. Blons, I. de Waziers, F. Carnot, A.-M. Houllier, T. Soussi, D. Brasnu, P. Beaune, O. Laccourreye, and P. Laurent-Puig
p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series
J. Clin. Oncol., April 7, 2000; 18(7): 1465 - 1473.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
S. Franklin, T. Pho, F. W. Abreo, R. Nassar, A. De Benedetti, F. J. Stucker, and C.-A. O. Nathan
Detection of the Proto-oncogene eIF4E in Larynx and Hypopharynx Cancers
Arch Otolaryngol Head Neck Surg, February 1, 1999; 125(2): 177 - 182.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.